Screener
Integra LifeSciences IART Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000917520-26-000058
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Intangible assets, net | 1,075,542 | 1,134,663 |
| Goodwill | 611,145 | 615,157 |
| Deferred tax assets, net | 70,443 | 69,854 |
| Other assets | 31,591 | 37,880 |
| Total assets | $3,563,490 | $3,602,001 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Current portion of borrowings under senior credit facility | $43,594 | $38,750 |
Item 1. Financial Statements
FAQ
- What is Integra LifeSciences's deferred tax assets and other non-current assets?
- Integra LifeSciences (IART) reported deferred tax assets and other non-current assets of $31.59M in Q2 2026.
- How has Integra LifeSciences's deferred tax assets and other non-current assets changed year-over-year?
- Integra LifeSciences's deferred tax assets and other non-current assets decreased by 31.7% year-over-year, from $46.24M to $31.59M.
- What is the long-term trend for Integra LifeSciences's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Integra LifeSciences's deferred tax assets and other non-current assets has grown at a 27.4% compound annual growth rate (CAGR), from $11.28M to $37.88M.
Ask your AI about Integra LifeSciences's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude